Arlington, MA, United States of America

Guolin Zhao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biogen Ma Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guolin Zhao. Retrieved from https://idiyas.com/inventor/guolin-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guolin Zhao: Innovator in Spinal Muscular Atrophy Treatment

Introduction

Guolin Zhao is a notable inventor based in Arlington, MA, who has made significant contributions to the field of medical research. His work primarily focuses on developing methods for treating spinal muscular atrophy (SMA), a genetic disorder that affects motor neurons and leads to muscle weakness.

Latest Patents

Guolin Zhao holds a patent for "Methods of treating spinal muscular atrophy." This patent features biomarkers that are crucial for the diagnosis and prognosis of SMA. Additionally, it includes methods for identifying responders to treatment and outlines approaches for treating subjects afflicted with this condition.

Career Highlights

Zhao is associated with Biosen MA Inc., where he applies his expertise to advance research in neuromuscular disorders. His innovative work has the potential to improve the quality of life for individuals suffering from SMA.

Collaborations

Throughout his career, Guolin Zhao has collaborated with esteemed colleagues such as Wildon Farwell and John Staropoli. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.

Conclusion

Guolin Zhao's contributions to the treatment of spinal muscular atrophy exemplify the impact of innovation in medical science. His work not only advances our understanding of SMA but also paves the way for future breakthroughs in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…